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Pediatric acute-onset neuropsychiatric syndrome (PANS) and pediatric autoimmune
neuropsychiatric disorders associated with streptococcal infections syndrome
(PANDAS) are conditions that impair brain normal neurologic function, resulting in the
sudden onset of tics, obsessive-compulsive disorder, and other behavioral symptoms.
Recent studies have emphasized the crosstalk between gut and brain, highlighting
how gut composition can influence behavior and brain functions. Thus, the present
study investigates the relationship between PANS/PANDAS and gut microbiota ecology.
The gut composition of a cohort of 30 patients with PANS/PANDAS was analyzed
and compared to control subjects using 16S rRNA-based metagenomics. Data were
analyzed for their α- and β-diversity; differences in bacterial distribution were detected by
Wilcoxon and LEfSe tests, while metabolic profile was predicted via PICRUSt software.
These analyses demonstrate the presence of an altered bacterial community structure
in PANS/PANDAS patients with respect to controls. In particular, ecological analysis
revealed the presence of two main clusters of subjects based on age range. Thus, to
avoid age bias, data from patients and controls were split into two groups: 4–8 years old
and >9 years old. The younger PANS/PANDAS group was characterized by a strong
increase in Bacteroidetes; in particular, Bacteroides, Odoribacter, and Oscillospira
were identified as potential microbial biomarkers of this composition type. Moreover,
this group exhibited an increase of several pathways concerning the modulation
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of the antibody response to inflammation within the gut as well as a decrease in
pathways involved in brain function (i.e., SCFA, D-alanine and tyrosine metabolism,
and the dopamine pathway). The older group of patients displayed a less uniform
bacterial profile, thus impairing the identification of distinct biomarkers. Finally, Pearson’s
analysis between bacteria and anti-streptolysin O titer reveled a negative correlation
between genera belonging to Firmicutes phylum and anti-streptolysin O while a positive
correlation was observed with Odoribacter. In conclusion, this study suggests that
streptococcal infections alter gut bacterial communities leading to a pro-inflammatory
status through the selection of specific bacterial strains associated with gut inflammation
and immune response activation. These findings highlight the possibility of studying
bacterial biomarkers associated with this disorder and might led to novel potential
therapeutic strategies.
Keywords: PANS, PANDAS, gut microbiota, dysbiosis, bacterial biomarkers
INTRODUCTION
Pediatric acute-onset neuropsychiatric syndrome (PANS) refers
to a clinical spectrum of neuropsychiatric disorders triggered by
environmental conditions, metabolic disorders, and/or infections
(Swedo et al., 2012). Children with PANS experience a
striking onset of neuropsychiatric symptoms, which include
obsessions/compulsions, food restriction, personality changes,
emotional lability, sleep disturbances, and even characteristics
of mood disorders (Mangiola et al., 2016). Subjects are usually
initially diagnosed with obsessive-compulsive disorder (OCD)
and/or an eating disorder, but the sudden onset of symptoms
distinguishes PANS from the other similar conditions.
The concept of PANS is relatively recent and is derived from
research on pediatric autoimmune neuropsychiatric disorders
associated with streptococcal infections syndrome (PANDAS);
PANDAS is now considered as a specific subset within the
broader clinical spectrum of PANS.
PANDAS was first described in 1998 by Dr. Swedo of the
National Institute of Mental Health (NIMH), who proposed
five diagnostic criteria: (1) the presence of tic and/or OCDs;
(2) prepubertal onset; (3) acute symptom onset and relapsing-
remitting course; (4) temporal association with Group A
streptococcal infection (GAS); and (5) the presence of associated
neurologic abnormalities (Swedo et al., 1998). Additional
symptoms observed in these patients were loss of motor skills,
behavioral disorders (i.e., hyperactivity, mood changes, and
irritability), and food restriction (Murphy et al., 2004).
The temporal association with GAS infection led to the
hypothesis of an autoimmune pathogenesis of this disorder
similar to Sydenham chorea, an established sequela of rheumatic
fever in which specific streptococcal antibodies cross-react
against some brain antigens through the process of molecular
mimicry (Murphy et al., 2010; Frankovich et al., 2015).
Although some studies (Kirvan et al., 2006; Toufexis et al., 2015)
have demonstrated clinical homogeneity of PANS/PANDAS
patients, certain aspects of this condition still remain elusive
(i.e., the interval between the inciting infection and the
onset of symptoms), leading to a heated scientific debate
(Macerollo and Martino, 2014). Data reported thus far have
failed to identify a distinct biological marker for PANS/PANDAS.
Recently, there has been a growing interest in gut microbiota
(GM), particularly regarding its relationship with brain function
(the so-called gut–brain axis; Clapp et al., 2017). Current
advances in sequencing and bioinformatics technologies have
allowed the investigation of possible correlations between gut
microbial composition and several pathological conditions
including inflammatory bowel disease (IBD), metabolic
disorders, allergies, and neurological disorders (Karlsson et al.,
2013; Ferreira et al., 2014; Putignani et al., 2016; Rachid and
Chatila, 2016; Dinan and Cryan, 2017; Dzidic et al., 2017).
A bidirectional communication appears to exist between the gut
and the brain, through which each can influence the other. In
particular, the gut interacts with the brain through the spinal
cord, the enteric nervous system, the hypothalamic pituitary
adrenal axis, and the central nervous system (CNS; Carabotti
et al., 2015). This relationship is well supported by studies that
have investigated the effects of probiotics, antibiotics, or even
germ-free animals on brain activity and function (Desbonnet
et al., 2015; Diaz Heijtz, 2016; Hoban et al., 2016). Given these
data, the present work seeks to assess the composition of GM
in subjects affected by PANS/PANDAS in order to obtain
further physiological information regarding the gut–brain axis
in this poorly understood disorder. The identification of gut
microbial biomarkers of disease could play an important role in
PANS/PANDAS clinical management.
MATERIALS AND METHODS
Patients
A total of 30 consecutive PANS/PANDAS patients aged
4–16 years (average age 10.03 years, SD ± 3.47; 20 males
and 10 females) were recruited at the Umberto I Hospital
(Rome, Italy) and Agostino Gemelli Hospital (Rome, Italy)
and sent to the Unit of Human Microbiome of “Bambino
Gesù” Children’s Hospital (OPBG; Rome, Italy) for microbial
diagnostics procedures.
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Diagnosis of PANS/PANDAS was made based on the current
diagnostic criteria (Swedo et al., 2004; Chang et al., 2015).
From each patient, the following data were collected: age,
gender, the presence of gastrointestinal disorders, the presence of
inflammatory and/or infective and/or chronic diseases, asthma,
allergies, consumption of antibiotics and probiotics, diet, and
anti-streptolysin O titer (ASLOT; Table 1). Patients were age-
matched with a cohort of 70 healthy controls (CTRL), screened
using a survey provided by the OPBG Human Microbiome Unit
on pediatric GM programming.
Inclusion criteria for both PANS/PANDAS patients and CTRL
were the absence of any inflammatory, infective, and/or chronic
diseases at the time of the microbiota analysis; all antibiotic and
pre-probiotic intake was to have been suspended beginning 4 or
2 months prior to the GM test (Table 1).
The study protocols (1404_OPBG_2017) were approved by
the OPBG Ethics Research Committee, in accordance with
the Declaration of Helsinki (as revised in Seoul, South Korea,
October 2008).
DNA Extraction and Targeted
Metagenomics
All fecal samples collected from PANS/PANDAS patients and
CTRL subjects were handled at the OPBG Human Microbiome
Unit for biobanking and targeted-metagenomics processing. For
each patient, three stool samples from consecutive days were
collected and genomic DNA was extracted following the QIAamp
DNA Stool Mini Kit (Qiagen, Germany) procedure. Next, the
bacterial 16S ribosomal RNA (rRNA) gene was amplified using
the primer set specific for the V1–V3 regions and the obtained
PCR products were purified, quantified, and pooled in an
equimolar way in a final amplicon library that was finally
sequenced on a 454-Junior Genome Sequencer (Roche 454 Life
Sciences, Branford, FL, United States). A first screening analysis
of read counts versus α-diversity indices (i.e., Observed) was used
to avoid stochastic effects during PCR and sequencing processes,
thereby selecting the sample with the highest values of reads and
α-diversity indices out of three collected samples to represent the
microbial variability present in the gut of each subject.
MG Data Open Access Repository
All 454 sequencing raw reads and associated metadata are
available at NCBI: Bioprojects: PRJNA420009, gut metagenomic
profile from PANS/PANDAS patients; PRJNA280490, gut
metagenomic profile from healthy subjects1.
Data Analysis
Reads were analyzed using the micca v1.6 pipeline2 (Albanese
et al., 2015). To characterize the taxonomic structure of the
samples, sequences were organized into operational taxonomic
units (OTUs) by clustering at a threshold of 97% pairwise
identity; representative sequences were classified using the
VSEARCH-based consensus classifier and the Greenenes 13_8
database (Rognes et al., 2016). Then, the PyNAST v.0.1 program
1http://www.ncbi.nlm.nih.gov/bioproject/?term=
2http://www.micca.org/
was used to perform a multiple sequence alignment (MSA;
Caporaso et al., 2010) against the Greengenes 13_08 database
filtered at 97% similarity for bacterial sequences; the MSA was
then used to build the phylogenetic tree (DeSantis et al., 2006).
Statistical analyses were computed using the R package,
phyloseq, for α- and β-diversity (McMurdie and Holmes, 2013),
while the identification of differences in the relative abundances
of taxa as well as the OTU correlation between PANS/PANDAS
patients and CTRL subjects was assigned using Wilcoxon rank-
sum (corrected for FDR) and Pearson tests (Hmisc package
in R), respectively. Furthermore, the adonis function in the R
package, vegan, was used to perform a PERMANOVA test on
β-diversity with 999 permutations considering even age groups
(corresponding to 4–6, 7–8, 9–10, 11–12, 13–16, and 20–30 years
old) using the “strata” argument within the adonis function.
To gain more insight into the metagenomic function of
the PANS/PANDAS patients microbiome, the PICRUSt v.1.1.0
tool was used (Langille et al., 2013); function predictions were
analyzed using the HUMAnN2 v0.99 program to identify the
Kyoto Encyclopedia of Genes and Genomes (KEGGs) pathway3
(Abubucker et al., 2012).
Finally, to identify possible OTU and KEGG biomarkers
associated with PANS/PANDAS, a linear discriminant effect size
(LEfSe) analysis was performed (Segata et al., 2011) with α value
for the statistical test equal to 0.05 and a logarithmic LDA score
threshold of 2.0.
RESULTS
Bacterial Ecology and Distribution in
PANS/PANDAS and CTRL Groups
After performing quality assessment and filtering of the reads, the
read counts and Observed values for each of the three samples
provided by each patient were evaluated in order to select the
most representative sample for each subject (Supplementary
Figure S1). Then, the GM biodiversity for both PANS/PANDAS
and CTRL groups was analyzed via α- and β-diversity values.
PANS/PANDAS patients showed an overall lower level of all
α-biodiversity indices taken into account in this study (Figure 1),
which was statistically significant using the Wilcoxon test for
Observed (p < 0.01) and Chao1 indices (p < 0.05), while
statistical significance was not reached for the Shannon index,
although PANS/PANDAS subjects exhibited lower mean values.
Three ecological indices were used to evaluate the
compositional dissimilarity between groups both in terms of
species abundance (i.e., Bray–Curtis distance) and incorporating
their phylogenetic relatedness (i.e., unweighted and weighted
UniFrac). When analyzing β-diversity, a strong separation on
the first axis (PERMANOVA p < 0.01) was observed for both
Bray–Curtis and unweighted UniFrac analyses in which a small
subset of CTRL samples was substantially separated from the
rest of the dataset (Figure 2). Plotting the data by age range, the
separated samples were found to be restricted to subjects in the
4–6 and 7–8 years old age CTRL groups.
3http://huttenhower.sph.harvard.edu/humann2
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FIGURE 1 | Boxplots representing α-diversity indices: Observed, Chao1, and Shannon. The plots represent the median, 25th, and 75th percentiles calculated for
PANS/PANDAS (blue) and CTRL (red) groups. The corresponding p-values are reported on the top of each index.
Though less evident, a similar trend was visible
(PERMANOVA p < 0.05) even when utilizing the weighted
UniFrac analysis. Therefore, in order to prevent possible bias
linked to age-related patterns of variability rather than to the
disorder, subsequent analyses were carried out by dividing the
global dataset into two age classes: a first group including subjects
in the 4–8 year range (y-PAN) and a second group including
subjects >9 years old (o-PAN). CTRL subjects were divided into
the same age classes and matched with their peers.
The α-diversity analysis recomputed using the y-PAN group
confirmed the previously observed profile. In particular, y-PAN
patients exhibited even lower values of α-diversity indices
(Figure 3A). Although lacking statistical significance, y-PAN
patients also exhibited a trend toward reduced biodiversity and
a high homogeneity for both the Observed and Chao1 indices,
while they placed near to the CTRL group for the Shannon index.
These differences are reflected in the distribution of relative
abundances of bacterial families and genera among the three
groups (Supplementary Figure S2).
Microbiota Description and Metabolic
Profile Prediction in y-PAN and CTRL
To look for distinctive features of the y-PAN group, taxa
distribution was investigated at the phyla, family, and genus
levels. Results of the Wilcoxon test highlighted OTU abundance
differences at the phylum level (Figure 4), with a higher
percentage of Bacteroidetes and a lower level of Firmicutes in
y-PAN children compared to CTRL subjects. In addition, subjects
in the y-PAN group exhibited a very low although non-significant
distribution of Actinobacteria and a total absence of the TM7
phylum.
At the family level, most members of the Bacteroidetes
phylum had higher relative abundance within y-PAN group,
particularly Bacteroidaceae (with a mean value higher than
50%), Rikenellaceae, and Odoribacteriaceae. Conversely, several
Firmicutes families such as Turicibacteraceae, Tissierellaceae,
Gemellaceae, and Carnobacteriaceae (of the Bacilli class);
Corynebacteriaceae and Lachnospiraceae (of the Clostridia class);
and Erysipelotrichaceae were absent. Even Bifidobacteriaceae
(Actinobacteria) were completely missing from the GM of
y-PAN patients in this young age class (Supplementary
Figure S3). Based on the OTU distribution, the LEfSe program
was used to identify possible microbial biomarkers associated
with PANS/PANDAS. As expected, the Bacteroidetes phylum
was found to be a biomarker of y-PAN group, including
Bacteroidaceae, Rikenellaceae, and Odoribacteriaceae at the
family level as well as Odoribacter, Bacteroides, and Oscillospira
at the genus level (Figure 5A). In particular, Bacteroidaceae
were present in all y-PAN samples at higher levels than in
the CTRL group (Figure 5B). On the other hand, the CTRL
group GM was characterized by several Firmicutes family
biomarkers, which were almost completely absent within y-PAN
group. In addition, other biomarkers found in the CTRLs GM
were absent or present at very low frequencies in the GM of
PANS/PANDAS patients. Within Firmicutes phylum, potential
biomarkers included Turicibacteriaceae, Erysipelotrichaceae, and
Lachnospiraceae; the two latter were found at very low levels
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FIGURE 2 | Principal coordinate analysis plot of PANS/PANDAS and CTRL groups. The plots show the first two principal coordinates (axes) for principal coordinates
analysis (PCoA) using Bray–Curtis (A), unweighted UniFrac (B), and weighted UniFrac (C) algorithms. The resulting p-values for PERMANOVA analyses are reported
in the figures.
in y-PAN patients’ GM, with low distributions of the Dorea,
Roseburia, and Coprococcus genus, while Turicibacter was
absent.
By analyzing how these biomarkers correlated with the
other OTUs within the microbiota ecology, a major cluster
related to y-PAN patients was observed in which the three
family biomarkers (i.e., Bacteroidaceae, Rikenellaceae, and
Odoribacteriaceae) were located together with other microbial
families (Supplementary Figure S4). This cluster in particular
was also composed of other Bacteroidetes families (such as
Barnesiellaceae and Prevotellaceae), Actinobacteria families
(such as Coriobacteriaceae and Proponiobacteriaceae),
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FIGURE 3 | Boxplots representing α-diversity indices: Observed, Chao1, and Shannon. The plots represent the median, 25th, and 75th percentiles calculated for
PANS/PANDAS (blue) and CTRL (red) group. Here, subjects (both patients and CTRL) are first segregated by age range: (A) y-PAN (4–8 years old) and (B) o-PAN
(>9 years old). The corresponding p-values are reported on the top of each index.
Verrucomicrobiaceae, and an unknown family of Clostridiales.
Within this cluster of families, which were all positively
correlated with each other, Bacteroidaceae had the highest
relative abundance and a strong negative correlation with all
other cluster families. However, within the CTRL GM cluster,
the identified OTUs exhibited a completely different ecology
and correlation pattern. Indeed, multiple small clusters rather
than one major one represented the microbial ecology. The
particular GM composition of y-PAN patients was associated
with a specific KEGG pathway (Figure 6), as highlighted
by the PICRUSt analysis. Specifically, y-PAN microbiota
expressed mostly KEGGs associated with glycan biosynthesis
and degradation (i.e., ko00511, ko00531, and ko00540), fatty
acids biosynthesis (ko00785), as well as energy (ko00020 and
ko00450) and vitamin metabolism (ko00740, ko00790, and
ko00670). In contrast, those KEGGs identified in the y-PAN
group lacked several of the pathways expressed at high levels in
the CTRL group, such as those involved in immune response
modulation (ko00621 and ko01040) and in neurological
functions (i.e., ko00350, ko00473, ko00300, ko00410, and
ko00380).
Microbiota Description in o-PAN Patients
The OTU distribution of the second group of o-PAN patients had
a less organized profile. LEfSe analysis failed to identify specific
microbial biomarkers associated with this group, while a simple
Wilcoxon test detected four differences in family distributions
between o-PAN and CTRL subjects (Supplementary Figure S5).
In particular, the o-PAN group was characterized by higher
levels of Peptostreptococcaceae and Erysipelotrichaceae and
reduced levels of Rikenellaceae and Barnesiellaceae. Although
these families showed significant differences with respect to the
CTRL group, they did not show uniform distributions within
o-PAN samples.
In general, o-PAN patients were characterized by a very high
level of diversity as already highlighted by α-diversity analysis
(Figure 3B), and therefore an uneven OTUs profile.
Anti-streptolysin O Titer and Bacterial
Genera Correlations
Pearson’s correlation was utilized to further investigate the
possible relationship between PANS/PANDAS OTUs and ASLOT
(Table 1). At first, this correlation was carried out using the entire
dataset without any significant results. This analysis was repeated
by selecting only ASLOT values higher than 500 units (Cardona
and Orefici, 2001) and reported not more than 5 months prior to
GM analysis to ensure titer stability (8/30 patients). The latter test
showed a significant negative correlation between ASLOT and
Dehalobacterium, Corynebacterium, Gemella, and Lactobacillus
as well as a positive association with Odoribacter (Supplementary
Figure S6).
DISCUSSION
Considering the distribution of α-diversity values calculated
using the entire dataset of PANS/PANDAS patients, it was
possible to observe a significant low value for both Observed
and Chao1 indices, thus suggesting that a lower OTU number
(including rare OTUs) distinguishes PANS/PANDAS patients
from CTRL group. However, the Shannon index did not reveal
a statistical significance between the two groups analyzed. The
β-diversity analysis identified a clear cluster of CTRL subjects
belonging to both the 4–6 and 7–8 age ranges that was
substantially separate in composition, from a phylogenetic point
of view (unweighted UniFrac), from the rest of the CTRL group
subjects and from peer PANS/PANDAS patients. Indeed, age can
greatly influence GM composition, especially during early stages
of life (Rodríguez et al., 2015; Odamaki et al., 2016). Thus, on the
basis of these data, PANS/PANDAS patients and the CTRL group
subjects were split into two age groups [4–8 (y-PAN) and >9
years old (o-PAN)], to remove possible age-related bias in further
analyses.
Re-performing α-diversity analyses on the two age
groups, again a lower level of α-diversity was observed for
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FIGURE 4 | Bar chart representing Wilcoxon test results on operational taxonomic units (OTUs) at the phylum level of gut microbiota from the CTRL and y-PAN
groups. Error bars for y-PAN patients are reported in blue while they are in orange for the CTRL subjects. The asterisks indicate the statistical significance (p < 0.05)
between the two groups.
PANS/PANDAS patients compared to CTRL subjects, confirming
the data from the previous analysis. This seems to suggest a
relationship between the disease and gut composition, regardless
of the patients’ age range. The y-PAN patients had higher levels
of homogeneity and very low standard deviations (i.e., Chao1
index), together with reduced levels of biodiversity compared to
their control peers, showing an evident loss of species diversity
in patients. Interestingly, concerning the Shannon index results,
patients had an OTU distribution similar to that of the CTRL
subjects. Thus, the loss of biodiversity was limited and not so
evident in all α-diversity indices, possibly suggesting that y-PAN
group is characterized by a low degree of dysbiosis, which is
defined as an imbalanced OTU distribution within the GM,
normally associated with some pathologic conditions (Carding
et al., 2015). Therefore, it appears that the y-PAN microbiota
is populated by fewer microbial species than CTRL GM, but in
their own form of equilibrium within the intestinal tract.
At the phylum level, the Wilcoxon test highlighted the
reduction of Firmicutes and TM7 phyla in y-PAN, along with a
major enrichment in Bacteroidetes. This phylum was identified
as a microbial marker by LEfSe analysis, thus suggesting that its
abundance in the y-PAN gut is strongly inhibiting colonization
by other phyla. Bacteroidetes is important to host energy yield
through the fermentation of non-digestible polysaccharides and
the production of short fatty acids (SCFAs) along with the CO2
and H2 gas, which are consumed by other members of gut
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FIGURE 5 | OTU biomarkers associated with y-PAN and CTRL groups. (A) A linear discriminant effect size (LeFse) analysis was performed (α value = 0.05,
logarithmic LDA score threshold = 2.0). (B) The cladogram represents the phylogenetic relationship of significant OTUs associated with each group.
microbial community (Topping and Clifton, 2001; Macfarlane
and Macfarlane, 2003; Johnson et al., 2017). Based on its
metabolic functions, it is not surprising that Bacteroidetes plays
such a central role in host physiology and that changes in its
relative abundance are associated with metabolic disorders (Qin
et al., 2012; Kolmeder et al., 2015).
Results obtained from y-PAN patients highlight the presence
of a clear disequilibrium between Firmicutes and Bacteroidetes
compared with subjects in the CTRL group; this disequilibrium
may be responsible for altered metabolic function (Boulangé
et al., 2016; Maier et al., 2017). Indeed, a different KEGG profile
is found when comparing y-PAN and CTRL samples in the
present study. Specifically, y-PAN samples were characterized by
several signs of inflammation and increased cellular metabolism.
In fact, their microbiota was enriched in glycan degradation,
TCA cycle (tricarboxylic acid), and lipoic acid biosynthesis (a
part of FA biosynthesis) capacities, which are part of a specific
metabolic profile associated with a higher acetyl-CoA and SCFA
production by gut microbial communities (Kim et al., 2016). Kim
et al. (2016) have demonstrated that this same metabolic pathway
leads to a higher B cell differentiation and Ig production, thus
enhancing host antibody response. B cells play a primary role
in immunity due to their antigen presentation capacity, which
allows them to influence T cell differentiation (Courtemanche
et al., 2004; Crawford et al., 2006). Moreover, y-PAN microbiota
seems to have increased folate biosynthesis capacity that is
known to influence the proliferation of CD8+ T cell lymphocytes
(Huang et al., 1999). Given these data, it is possible to speculate
that, in y-PAN subjects, the increase in this specific metabolic
pathway in GM can lead to enhanced immune responses and
perhaps even excess inflammation. This hypothesis is further
supported by the presence in these patients of Odoribacteriaceae
(genus Odoribacter), Bacteroidaceae (genus Bacteroides), and
Rikenellaceae all of which are positively associated with pro-
inflammatory status in several metabolic and autoimmune
diseases (Swidsinski et al., 2005; Giannelli et al., 2014; Costello
et al., 2015).
These three families, Odoribacteriaceae, Bacteroidaceae, and
Rikenellaceae, are in the middle of a large bacterial cluster in the
network analysis with strong positive or negative correlations. In
particular, Bacteroidaceae, which is the most abundant family of
the three biomarkers, exhibits a strong negative correlation to all
other families; thus, its increase is paralleled by a disadvantage to
all others.
An additional microbial biomarker found in y-PAN samples
is Oscillospira, normally associated with healthy conditions (Zhu
et al., 2013; Walters et al., 2014; Del Chierico et al., 2017). Its
presence here is likely due to the higher abundance of Bacteroides
in y-PAN patients; Bacteroides are strong producers of fermented
products consumed by Oscillospira (Konikoff and Gophna, 2016).
However, the metabolic profile of y-PAN microbiota also
characterized by the lack of several expected KEGGs founded in
CTRL microbiota. First, there was a low presence of important
anti-inflammatory elements such as dioxin degradation and
unsaturated FA. While FA may inhibit the production of
IL-1β, IL-6, IL-8, and TNFα, dioxin is a strong environment
contaminant with immunomodulatory abilities due to its
receptor (the aryl hydrocarbon receptor). Dioxin is found in all
immune system cells and seems to play an important role in
IBD (Arsenescu et al., 2011). The identification of these KEGG
biomarkers in the CTRL group confirms the inflammatory status
of y-PAN patients.
The present study gives evidence of the absence of specific
pathways involved in certain neuronal functions, included a
lower abundance microbiota capable of tyrosine metabolism in
y-PAN patients. Tyrosine is a non-essential amino acid that
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FIGURE 6 | KEGG biomarkers associated with the y-PAN and CTRL groups. A linear discriminant effect size (LeFse) analysis has been performed (α value = 0.05,
logarithmic LDA score threshold = 2.0).
is the major precursor of dopamine production via tyrosine
hydroxylase (TH; Daubner et al., 2011). A reduction in tyrosine
metabolism has been associated with some neuronal pathologies
such as Parkinson’s disease (DiFrancisco-Donoghue et al.,
2014). The link between tyrosine and dopamine metabolism
could be an interesting perspective with which to interpret
PANS and PANDAS disorder in young children, since this
neurotransmitter regulates learning and modulates circadian
rhythm (Korshunov et al., 2017). It has been proposed that the
abnormalities in behaviors in y-PAN children may be caused
by autoantibody activity against brain antigens (Cunningham
and Cox, 2016), potentially induced by Streptococcus pyogenes
infections through a process of cross-mimicry that leads to the
production of antibodies against the dopamine receptor (Cox
et al., 2013; Orefici et al., 2016). This same process may also shape
the types of microbiota present in the gut by selecting for certain
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FIGURE 7 | Descriptive model of PANS/PANDAS brain–gut microbiota axis. Model suggests that streptococcal infection can alter gut microbial communities leading
to an increment of Bacteroides, Odoribacter, and Oscillospira, and to a reduction of Roseburia, Clostridiales, Lachnospiraceae, and Erysipelotrichaceae. KEGG
analysis showed an increment of pro-inflammatory pathways and a reduction of anti-inflammatory and neurological predicted metabolites, respectively. This
condition could affect dopamine pathways, N-methyl-D-aspartate (NMDA)–glycine binding site and antibodies modulation leading to behavior impairments.
KEGG capacities in y-PAN patients. Modulation of dopamine
production by the GM in PANS/PANDAS patients is further
supported by the lack of Clostridiales families in y-PAN patients.
Clostridia have a crucial role in gut homeostasis and host defense
mechanisms against exogenous infections (Lopetuso et al., 2013).
Interestingly, an in vivo experiment has found an association
between the presence of Clostridia and increased norepinephrine
and dopamine in the gut lumen (Asano et al., 2012). These
data are in accordance with our finding of Clostridia almost
exclusively in the CTRL group compared to the PANS/PANDAS
group.
Interestingly, CTRL subjects exhibited higher levels of
Roseburia genus members (Lachnospiraceae, Clostridial cluster
XIVa); this observation deserves attention as this genus
contributes to the maintenance of gut homeostasis, the ability to
preserve gut barrier function, and for its anti-inflammatory effect
due to butyrate production (Velasquez-Manoff, 2015).
In addition, D-alanine metabolism, as a KEGG biomarker,
was increased in samples from CTRL subjects. D-Alanine is
a D-amino acid present in the human CNS and is a strong
agonist at the N-methyl-D-aspartate (NMDA)–glycine binding
site (McBain et al., 1989). Hypofunction of D-alanine and
NMDA receptors has been associated with some neurological
dysfunctions such as encephalitis and schizophrenia (Tsai
et al., 2006). Recently, antibodies against NMDA receptors
have been detected after viral infection (Gable et al., 2009).
Given these data, it is possible to speculate that the low
level of D-alanine in y-PAN patients is due to an unknown
antibody-mediated process linked to the streptococcal infection.
During infection, anti-streptococcal/anti-neuronal antibodies are
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generated. It is possible that they are able to mediate the
destruction of healthy neurons (via the NMDA receptor) through
a mechanism of molecular mimics (Murphy and Pichichero,
2002).
Gut microbiota from the y-PAN patients was also
characterized by the absence of the Erysipelotrichaceae family,
which seems to be correlated with several immunologic
conditions. Erysipelotrichaceae species may induce different
immunologic responses; for example, Erysipelotrichaceae have
been found to attract more IgA molecules than other gut
microbial families (Palm et al., 2014). When trying to understand
their absence in y-PAN patients’ GM, it is interesting to note that
y-PAN patients may also have an IgA deficiency (Kawikova et al.,
2010).
In the second group of o-PAN (≥9 years old) patients,
Erysipelotrichaceae were in some way more abundant in the
GM than in CTRL GM, although the great variability within the
o-PAN group must be underlined. Indeed, LEfSe analysis failed in
this case to find a pathological biomarker of this great variability
in OTU profiles within the o-PAN group. The high heterogeneity
within this group of patients is probably linked to the intense and
repeated antibiotic treatments that they have undergone during
their life. Indeed, antibiotic treatment seriously affects microbiota
composition and function, sometimes even producing long-term
deleterious effects (Becattini et al., 2016). Therefore, repeated
antibiotic therapy (in association with other pharmacological
treatments) has probably altered GM composition, making it
difficult to detect possible microbial markers associated with
the o-PAN syndrome. Thus, the GM in y-PAN subjects can
be regarded as being in a “naïve” and in a baseline state from
pathophysiological point of view. Future studies should better
elucidate how microbiota changes during early stages of y-PAN
disease in order to clarify the confounding effects of antibiotic
therapy.
A Pearson’s test indicated that ASLOT is correlated with
several microbial genera that are present in a subset of
PANS/PANDAS patients characterized by anti-streptolysin O
values higher than 500 units. Several negative correlations were
obtained with a genus belonging to the Firmicutes phylum, which
seems to be in accordance with the low percentage of this phylum
among naïve y-PAN patients. On the other hand, Odoribacter
were strongly positively correlated with ASLOT values, which is
very interesting given that the same genus was also identified as
a putative microbial biomarker from the LEfSe analysis in y-PAN
patients.
Other cases have been reported in which Odoribacter
seems to correlate with high inflammation levels and with
behavioral dysfunction (including Alzheimer’s disease and
autism) (Bajaj et al., 2012; De Angelis et al., 2015; Shen
et al., 2017). A recent study has demonstrated that bacterial
strains involved in periodontitis (such as Porphyromonas
gingivalis) lead to systemic inflammation, even in distant
body sites such as GM via swallowing (Hajishengallis, 2014).
Therefore, given the involvement of S. pyogenes infection
in PANS/PANDAS etiology, it is plausible that the infection
influences GM composition and host inflammation by the same
mechanism.
CONCLUSION
The results obtained from this study suggest that streptococcal
infections can alter gut microbial communities leading to a pro-
inflammatory state in the gut by selecting for specific bacterial
strains that are normally associated with gut inflammation and
activation of the immune response (Figure 7). This condition
is likely maintained in patients, even after the infection itself
has resolved. Moreover, an altered GM composition could
have indirect effects by reducing the production of metabolites
involved in important brain functions such as SCFA, D-alanine
and tyrosine metabolism, and the dopamine pathway. Thus, the
GM composition may possibly influence behavior, as clinically
observed in PANS/PANDAS patients.
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FIGURE S1 | Sample selections based on the α-diversity analysis. The Observed
index was used to evaluate sample biodiversity level for each patient. In this plot,
patient ID is reported on the x-axis while the number of reads is reported on the
y-axis. Sphere dimension indicates α-diversity index values, while color intensity
reads values, respectively.
FIGURE S2 | Bar chart representing mean relative abundance of operational
taxonomic units (OTUs) at the family and genus level. The bar plots represent the
mean relative abundance of the 20 most abundant taxa at family (a) and genus
(b) level for CTRL, o-PAN, and y-PAN groups.
FIGURE S3 | Bar charts representing Wilcoxon test results on operational
taxonomic units (OTUs) at the family level of the CTRL and y-PAN groups. Bars for
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y-PAN patients are reported in blue. Bars are reported in orange for CTRL. Only
statistically significant comparisons are reported in the figure (p < 0.05).
FIGURE S4 | Network analysis. Spearman’s correlation analysis among OTUs
between the CTRL (a) and y-PAN (b) groups. Negative correlations are indicated
by red lines. Positive correlations are indicated by blue lines.
FIGURE S5 | Bar chart representing Wilcoxon test results on operational
taxonomic units (OTUs) at the family level between the CTRL and o-PAN groups.
Bars for o-PAN patients are reported in blue, while orange bars indicate CTRL
patients. Only statistically significant comparisons are reported in the figure
(p < 0.05).
FIGURE S6 | Pearson’s correlation test between ASLOT values and microbial
genus in PANS/PANDAS patients. Patients (8/30) were selected basing on ASLOT
values >500 units and time until detection <5 months from GM analysis. Both
negative and positive correlations (red and blue arrows, respectively) are
considered significant at p < 0.05. Rho values are reported for each correlation (r).
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